脑室内尼卡地平治疗儿童脑血管痉挛:病例系列
该研究回顾性分析了2006年至2023年间11例经脑室外引流接受脑室内尼卡地平预防或治疗脑血管痉挛的患儿,多数为青少年,8/11(73%)因颅内动脉瘤破裂导致蛛网膜下腔出血。全部患儿存活,出院时功能状态评分中位数为6,提示功能正常无缺陷。作者认为脑室内给予尼卡地平似乎是治疗儿童脑血管痉挛的安全替代方式,但需更大规模多中心前瞻性研究明确指征与方案。
要点
- 脑室内尼卡地平可用于儿童脑血管痉挛的预防或治疗,本系列11例均存活。
- 本组多数为青少年,8/11(73%)的病因为破裂颅内动脉瘤。
- 出院时功能状态评分中位数为6,提示功能正常无缺陷。
核心结论
- 在本回顾性病例系列中,脑室内给予尼卡地平似乎是治疗儿童脑血管痉挛的安全替代方式。
研究设计与样本
- 共识别11例经脑室外引流接受脑室内尼卡地平的患儿,采用标准描述性统计总结病例系列数据。
主要发现
- 多数患儿为青少年(10-17岁),8/11(73%)因破裂颅内动脉瘤导致蛛网膜下腔出血。
- 全部患儿存活,出院时功能状态评分中位数为6,提示功能正常无缺陷。
临床怎么用
- 对于儿童脑血管痉挛,在静脉钙通道阻滞剂可能导致全身低血压和脑灌注恶化时,可考虑脑室内尼卡地平作为替代方式。
- 本系列经脑室外引流给药,但治疗指征与给药方案尚需更大规模前瞻性研究明确。
局限性
- 本研究为单中心、回顾性、小样本(11例)病例系列,描述性统计,证据等级有限。
- 作者指出需更大规模多中心前瞻性儿童研究以更精确界定治疗指征、方案并改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment of cerebral vasospasm in children is challenging because administration of intravenous calcium channel blockers can cause systemic hypotension and worsened cerebral perfusion. Intraventricular nicardipine has been used as an alternative modality for treating vasospasm in adult subarachnoid hemorrhage populations. The literature describing intraventricular calcium channel blocker therapy for pediatric cerebral vasospasm is sparse. The goal of this study was to perform a descriptive, retrospective chart review of all children at our institution who received intraventricular nicardipine for the prevention of or treatment of cerebral vasospasm. METHODS: We queried the electronic medical record of our institution for all inpatients who had been prescribed intraventricular nicardipine from January 1, 2006, to December 31, 2023. Patients' charts were manually examined for relevant clinical information. Standard descriptive statistics were used to summarize the case series data. RESULTS: We identified 11 patients who had received intraventricular nicardipine via an external ventricular drain. Most children were adolescents (10-17 years old), and most patients (8/11; 73%) had a ruptured intracranial aneurysm as the cause of their subarachnoid hemorrhage. All patients survived with median Functional Status Scores of 6 at discharge, indicating normal function with no deficits. CONCLUSIONS: In our limited retrospective series of patients, intraventricular administration of nicardipine appears to be a safe alternative modality for management of cerebral vasospasm. Larger, multicenter, prospective pediatric studies are needed to more precisely define treatment indications, define regimens, and improve outcomes.
引用
- Ettinger NA, Futch HS, Coleman S, et al. Intraventricular Nicardipine for Cerebral Vasospasm in Children: A Case Series. World Neurosurg. 2026. PMID: 42392308. doi:10.1016/j.wneu.2026.125171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。